Case File №
#VI-2026-0260
Chimera Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
32 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C Okay | 7 | 6.7 | 4.7 | 8.0 | 13 Oct 2025 |
| Tirzepatide | X Unrated | 1 | 7.0 | 7.0 | 7.0 | 24 May 2026 |
| Adipotide | X N/A | 1 | 7.5 | 7.5 | 7.5 | 27 Feb 2025 |
| Alprostadil | X N/A | 1 | 6.5 | 6.5 | 6.5 | 9 Jun 2025 |
| Andarine S4 | X N/A | 1 | 4.0 | 3.9 | 3.9 | 13 Feb 2025 |
| Cartalax | X N/A | 1 | 8.3 | 8.3 | 8.3 | 2 Jul 2025 |
| Chonluten | X N/A | 1 | 4.0 | 2.5 | 2.5 | 9 Jun 2025 |
| Drostanolone Enanthate (Mast E) Raw | X N/A | 1 | 6.5 | 6.5 | 6.5 | 2 Apr 2025 |
| DSIP | X N/A | 1 | 5.2 | 5.2 | 5.2 | 21 May 2025 |
| Fluoxymesterone (Halotestin) Raw | X N/A | 1 | 7.6 | 7.6 | 7.6 | 20 Jun 2025 |
| GHRP-2 Acetate | X N/A | 1 | 4.9 | 4.9 | 4.9 | 13 Feb 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 9.2 | 9.2 | 9.2 | 13 Jun 2025 |
| GW-501516 (Cardarine) Raw | X N/A | 1 | 4.0 | 3.4 | 3.4 | 7 May 2025 |
| HGH 191AA (Somatropin) | X N/A | 1 | 4.9 | 4.9 | 4.9 | 14 Jan 2025 |
| KPV Oral | X N/A | 1 | 7.7 | 7.7 | 7.7 | 9 Jun 2025 |
| MAPA (methyl alpha-phenylacetoacetate) CAS 101-97-3 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 20 Jun 2025 |
| MOTS-C | X N/A | 1 | 5.3 | 5.3 | 5.3 | 2 Apr 2025 |
| MT-1 | X N/A | 1 | 7.3 | 7.3 | 7.3 | 2 Apr 2025 |
| NA Selank Amidate | X N/A | 1 | 6.1 | 6.1 | 6.1 | 3 Jul 2025 |
| NA Semax Amidate | X N/A | 1 | 6.2 | 6.2 | 6.2 | 16 Mar 2025 |
| Nandrolone Phenylpropionate (NPP) Raw | X N/A | 1 | 6.6 | 6.6 | 6.6 | 24 Apr 2025 |
| Nitroethane CAS 79-24-3 | X N/A | 1 | 5.0 | 5.0 | 5.0 | 28 Mar 2025 |
| Pancragen | X N/A | 1 | 6.3 | 6.3 | 6.3 | 14 Jan 2025 |
| PE 22-28 | X N/A | 1 | 7.4 | 7.4 | 7.4 | 2 Jul 2025 |
| Romosozumab | X N/A | 1 | 6.4 | 6.4 | 6.4 | 16 Mar 2025 |
| Selank | X N/A | 1 | 7.5 | 7.5 | 7.5 | 16 Mar 2025 |
| SNAP-8 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 |
| Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | X N/A | 1 | 5.0 | 5.0 | 5.0 | 2 Jul 2025 |
| T4 (Levothyroxine) | X N/A | 1 | 4.0 | 4.0 | 4.0 | 24 Apr 2025 |
| Test Undecanoate | X N/A | 1 | 5.2 | 5.2 | 5.2 | 6 May 2025 |
| Vitamin D3 20000iu/ml | X N/A | 1 | 8.1 | 8.1 | 8.1 | 9 Jun 2025 |
| Winstrol (Stanozolol) | X N/A | 1 | 4.0 | 3.5 | 3.5 | 25 Apr 2025 |
Exhibit II
Evidence Log
37 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Chonluten | 4.0 C | 2mg | 2.2mg | +10.3% | 96.34% | vcvz93 | Lab G | Public |
| 24 May 2026 | Alprostadil | 6.6 A | 30mg | 27.3mg | -9.0% | 98.28% | 1dsn6b | Lab F | Public |
| 24 May 2026 | MT-1 | 7.5 A | 5mg | 5.2mg | +3.9% | 99.44% | 14x2bm | Lab D | Community |
| 24 May 2026 | KPV Oral | 8.1 A | 25mg | 31.1mg | +24.3% | 98.48% | hrqdpt | Lab A | Public |
| 24 May 2026 | Vitamin D3 20000iu/ml | 8.1 A | 200mg/ml | 228.3mg/ml | +14.2% | 97.96% | nzdkbv | Lab F | Public |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 9.1 A | 50mg | 60.3mg | +20.5% | 95.07% | x26o0w | Lab A | Public |
| 23 May 2026 | SNAP-8 | 4.0 C | 20mg | 19.1mg | -4.4% | 95.81% | 2xyb1v | Lab D | Public |
| 22 May 2026 | Retatrutide | 6.5 B | 20mg | 22mg | +10.0% | 99.90% | (no batch ID) | Lab E | Public |
| 21 May 2026 | Retatrutide | 4.7 D | 20mg | 24.8mg | +24.0% | 99.80% | (no batch ID) | Lab G | Public |
| 21 May 2026 | MOTS-C | 4.0 C | 50mg | 43.4mg | -13.2% | 96.38% | qt16h9 | Lab A | Public |
| 21 May 2026 | Fluoxymesterone (Halotestin) Raw | 5.4 B | 5g | 6.1g | +22.1% | 95.86% | u3x888 | Lab A | Public |
| 20 May 2026 | Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | 4.0 C | 250mg/ml | 278.0mg/ml | +11.2% | 95.28% | fb24sk | Lab G | Public |
| 19 May 2026 | GW-501516 (Cardarine) Raw | 4.0 C | 100g | 85.6g | -14.4% | 98.83% | is9gz9 | Lab B | Public |
| 29 Jan 2026 | Nitroethane CAS 79-24-3 | 4.2 C | 5g | 5.7g | +13.3% | 99.99% | c57c6y | Lab B | Community |
| 22 Jan 2026 | Retatrutide | 7.2 A | 40mg | 43mg | +7.5% | 99.90% | (no batch ID) | Lab G | Public |
| 19 Jan 2026 | GHRP-2 Acetate | 6.2 A | 20mg | 17.6mg | -11.9% | 95.42% | c9glg1 | Lab A | Public |
| 19 Jan 2026 | HGH 191AA (Somatropin) | 7.2 A | 10mg | 12.0mg | +19.9% | 99.81% | 90ohyy | Lab G | Community |
| 9 Jan 2026 | DSIP | 4.0 C | 50mg | 57.2mg | +14.4% | 99.51% | f327al | Lab G | Public |
| 9 Jan 2026 | NA Semax Amidate | 7.4 A | 50mg | 44.7mg | -10.7% | 95.93% | 1d4zge | Lab F | Community |
| 6 Jan 2026 | Nandrolone Phenylpropionate (NPP) Raw | 6.6 A | 10g | 9.5g | -5.2% | 99.50% | kfx3m5 | Lab B | Public |
| 29 Dec 2025 | Retatrutide | 7.3 A | 10mg | 10.3mg | +3.0% | 99.60% | (no batch ID) | Lab G | Public |
| 29 Dec 2025 | Retatrutide | 7.3 A | 15mg | 15.1mg | +0.7% | 99.60% | (no batch ID) | Lab G | Public |
| 29 Dec 2025 | PE 22-28 | 4.4 C | 10mg | 11.5mg | +15.2% | 99.83% | a1dnzy | Lab B | Public |
| 12 Dec 2025 | Andarine S4 | 4.0 C | 50mg | 53.6mg | +7.2% | 95.68% | 45j26f | Lab B | Public |
| 5 Dec 2025 | Retatrutide | 6.3 B | 60mg | 66.4mg | +10.7% | 99.90% | (no batch ID) | Lab G | Public |
| 23 Nov 2025 | Adipotide | 8.7 A | 30mg | 37.1mg | +23.6% | 96.23% | xa60qy | Lab C | Public |
| 17 Nov 2025 | MAPA (methyl alpha-phenylacetoacetate) CAS 101-97-3 | 9.2 A | 5g | 4.8g | -4.0% | 96.37% | yiquo9 | Lab B | Public |
| 17 Nov 2025 | NA Selank Amidate | 6.4 A | 2mg | 1.9mg | -5.9% | 96.12% | o7fwok | Lab B | Community |
| 17 Nov 2025 | T4 (Levothyroxine) | 4.0 C | 10mg | 11.3mg | +12.9% | 97.03% | 37rl26 | Lab D | Public |
| 14 Nov 2025 | Drostanolone Enanthate (Mast E) Raw | 4.0 C | 500g | 557.4g | +11.5% | 96.97% | xmhgqz | Lab E | Community |
| 5 Nov 2025 | Romosozumab | 5.4 B | 2mg | 2.3mg | +14.1% | 99.34% | ehju4l | Lab G | Public |
| 5 Nov 2025 | Test Undecanoate | 7.3 A | 100mg/ml | 118.2mg/ml | +18.2% | 98.16% | 94mh8c | Lab E | Public |
| 17 Oct 2025 | Pancragen | 5.4 B | 2mg | 2.4mg | +17.7% | 96.29% | hprgja | Lab B | Public |
| 13 Oct 2025 | Retatrutide | 8.0 A | 20mg | 18.2mg | -9.0% | 99.60% | Purple Caps | Lab G | Public |
| 9 Oct 2025 | Cartalax | 6.3 A | 10mg | 12.2mg | +22.3% | 97.53% | tkcp63 | Lab C | Public |
| 9 Oct 2025 | Selank | 8.2 A | 10mg | 11.1mg | +11.1% | 96.18% | w415fc | Lab G | Public |
| 3 Oct 2025 | Winstrol (Stanozolol) | 4.3 C | 20mg | 22.4mg | +12.2% | 99.34% | 8xq7cd | Lab D | Public |
— END OF EVIDENCE LOG —